Advertisement

Advertisement

AU:IMM Stock Latest News

Immutep receives noncompliance notification from Nasdaq

The FlyImmutep receives noncompliance notification from Nasdaq

Immutep Faces Nasdaq Bid-Price Deficiency but Retains Listings as It Seeks Compliance

PremiumCompany Announcements

Immutep Faces Nasdaq Bid-Price Deficiency but Retains Listings as It Seeks Compliance

3d ago

Immutep Halts Key Lung Cancer Trial but Pipeline Advances on Solid Cash Base

PremiumCompany Announcements

Immutep Halts Key Lung Cancer Trial but Pipeline Advances on Solid Cash Base

3d ago

Immutep to Present New Eftilagimod Alfa Data at ASCO 2026

PremiumCompany Announcements

Immutep to Present New Eftilagimod Alfa Data at ASCO 2026

11d ago

Unusually active option classes on open April 15th

PremiumThe Fly

Unusually active option classes on open April 15th

17d ago

Immutep granted Orphan Drug Designation for eftilagimod alfa

PremiumThe FlyImmutep granted Orphan Drug Designation for eftilagimod alfa

17d ago

Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline

Company Announcements

Immutep Ends Key Lung Cancer Trial but Stresses Strength of Pipeline

25d ago

Immutep sees progress from Phase I study of LAG-3 agonist for autoimmune disease

The Fly

Immutep sees progress from Phase I study of LAG-3 agonist for autoimmune disease

1M ago

Insignia Financial Ceases to Be Substantial Holder in Immutep

PremiumCompany Announcements

Insignia Financial Ceases to Be Substantial Holder in Immutep

1M ago

Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761

PremiumCompany Announcements

Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761

1M ago

UBS Group Ceases to Be Substantial Shareholder in Immutep

PremiumCompany Announcements

UBS Group Ceases to Be Substantial Shareholder in Immutep

2M ago

Immutep downgraded to Hold from Buy at Maxim

PremiumThe Fly

Immutep downgraded to Hold from Buy at Maxim

2M ago

Adobe downgraded, Nio upgraded: Wall Street’s top analyst calls

PremiumThe FlyAdobe downgraded, Nio upgraded: Wall Street’s top analyst calls

2M ago

Immutep says IDMC recommends discontinuation for TACTI-004 Phase III study

The Fly

Immutep says IDMC recommends discontinuation for TACTI-004 Phase III study

2M ago

Immutep downgraded to Neutral from Outperform at Baird

The Fly

Immutep downgraded to Neutral from Outperform at Baird

2M ago

Immutep downgraded to Market Perform from Outperform at Citizens

PremiumThe Fly

Immutep downgraded to Market Perform from Outperform at Citizens

2M ago

Immutep Trading Resumes on ASX After Key Phase III Trial Update

PremiumCompany Announcements

Immutep Trading Resumes on ASX After Key Phase III Trial Update

2M ago

Immutep Halts Pivotal Lung Cancer Trial After Futility Review

PremiumCompany Announcements

Immutep Halts Pivotal Lung Cancer Trial After Futility Review

2M ago

Immutep Shares Suspended Pending Key Phase III Trial Futility Update

PremiumCompany Announcements

Immutep Shares Suspended Pending Key Phase III Trial Futility Update

2M ago

Immutep Halts Trading Ahead of Key Phase III Trial Futility Analysis

PremiumCompany AnnouncementsImmutep Halts Trading Ahead of Key Phase III Trial Futility Analysis

2M ago

Immutep Doubles Half-Year Loss as R&D Spend Surges Despite New Collaboration Revenue

Company Announcements

Immutep Doubles Half-Year Loss as R&D Spend Surges Despite New Collaboration Revenue

2M ago

Immutep initiated with an Outperform at Citizens

The Fly

Immutep initiated with an Outperform at Citizens

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >